These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 949360)

  • 1. [Parsalmide: a new anti-inflammatory agent. VI. Pharmacokinetic and metabolic aspects in man].
    Fleischmann L; Pedrazzoli A
    Boll Chim Farm; 1976 Feb; 115(2):183-94. PubMed ID: 949360
    [No Abstract]   [Full Text] [Related]  

  • 2. [Parsalmide: a new anti-inflammatory agent. V. Pharmacokinetic and metabolic aspects in the rabbit].
    Fleischmann L; Lavezzo A; Colombo L
    Boll Chim Farm; 1976 Feb; 115(2):175-82. PubMed ID: 949359
    [No Abstract]   [Full Text] [Related]  

  • 3. [Some aspects of the bioavailability and biotransformation in humans of parsalmide, a new synthetic substance with anti-inflammatory and analgesic action].
    Fleischmann L; Giacomelli A
    Clin Ter; 1977 Feb; 80(4):363-78. PubMed ID: 300663
    [No Abstract]   [Full Text] [Related]  

  • 4. [Parsalmide: a new anti-inflammatory agent. VII. Toxicological studies on tolerance in the rat].
    Gruber C; Guzzon V; Ferrero E
    Boll Chim Farm; 1976 Feb; 115(2):195-208. PubMed ID: 949361
    [No Abstract]   [Full Text] [Related]  

  • 5. Parsalmide: a new anti-inflammatory agent Note IX - Toxicological study of parsalmide; oral toxicity study in baboons.
    Mazue G; Berthe J; Richer G; Vallee E
    Boll Chim Farm; 1976 Feb; 115(2):216-29. PubMed ID: 820359
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetic and metabolic aspects of parsalmide in various animal species and man].
    Fleischmann L
    Boll Chim Farm; 1980 Jul; 119(7):385-90. PubMed ID: 6893933
    [No Abstract]   [Full Text] [Related]  

  • 7. [Parsalmide: a new anti-inflammatory agent. III. Study of the analgesic and anti-inflammatory activity].
    Ferrero E; Giudice A; Guzzon V; Pedrazzoli A
    Boll Chim Farm; 1976 Feb; 115(2):145-56. PubMed ID: 949357
    [No Abstract]   [Full Text] [Related]  

  • 8. [Parsalmide: a new anti-inflammatory agent. I. Synthesis and preliminary pharmacological activity of a series of 2-alkyloxy-5-amino-N-alkylbenzamides].
    Pedrazzoli A; Dall'asta L; Maffi G; Giudice A; Ferrero E
    Boll Chim Farm; 1976 Feb; 115(2):125-34. PubMed ID: 949355
    [No Abstract]   [Full Text] [Related]  

  • 9. [Parsalmide: a new anti-inflammatory agent. VIII. In vivo inhibiting effect on blast transformation of circulating lymphocytes in dogs].
    Gruber C; Uccellini M; Guzzon V; Ferrero E
    Boll Chim Farm; 1976 Feb; 115(2):209-15. PubMed ID: 949362
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolic aspects of parsalmide in the cat (author's transl)].
    Fleischmann L
    Arzneimittelforschung; 1980; 30(2):294-8. PubMed ID: 6892880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic aspects of new antipsychotic drugs.
    Dahl SG
    Neuropharmacology; 1981 Dec; 20(12B):1299-302. PubMed ID: 6119639
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parsalmide: a new anti-inflammatory agent. II. Chemico-physical and analytical characteristics].
    Maffi G; Dall'asta L; Pedrazzoli A
    Boll Chim Farm; 1976 Feb; 115(2):135-44. PubMed ID: 949356
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity of the antirheumatic benzofenac VUFB, in experimental animals and man, in relation to the species specificity of pharmacokinetics and biotransformation].
    Grimová J; Roubal Z; Koruna I; Nĕmecek O
    Cas Lek Cesk; 1982 Sep; 121(34-35):1078-82. PubMed ID: 7127389
    [No Abstract]   [Full Text] [Related]  

  • 14. The metabolic fate of seclazone in man.
    Edelson J; Schuster E; Shahinian S; Douglas JF
    Arch Int Pharmacodyn Ther; 1974 May; 209(1):66-74. PubMed ID: 4416360
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacokinetics of Benzofenac, a new non-steroidal anti-inflammatory drug, in experimental animals and man].
    Janků I; Roubal Z; Grimová J; Verner P; Nĕmecek O; Kameníková L; Elis J
    Cesk Farm; 1981 May; 30(3-4):93-102. PubMed ID: 7261075
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro mutagenicity of anti-inflammatory parsalmide analogues PA7, PA10, and PA31 triggered by biotransformation into hydroxy derivatives.
    Cardoso HS; Bicalho B; Genari P; Santagada V; Caliendo G; Perissutti E; Donato JL; De Nucci G
    Eur J Med Chem; 2006 Mar; 41(3):408-16. PubMed ID: 16417948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Absorption, elimination and metabolism of a new neuroleptic agent (FLO 1347) in the rat dog and man (author's transl)].
    Strolin-Benedetti M; Donath A; Frigerio A; Morgan KT; Laville C; Malnoe A
    Ann Pharm Fr; 1978; 36(5-6):279-88. PubMed ID: 30386
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic and pharmacokinetic study of bucloxic acid. II. Pharmacokinetic study in the baboon.
    Chasseaud LF; Fry BJ; Gros PM
    Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1390-7. PubMed ID: 4480069
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biotransformation of 2-phenyl-4-/beta-dimethylamino-ethyl/-6-methyl-2,3-dihydro-1,4-benzoxazine-3-one ("AR 17 O48) a potential antirheumatic agent].
    Pfeifer S; Bornschein I; Gehrke A
    Pharmazie; 1977 Oct; 32(10):587-92. PubMed ID: 607217
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspects of the clinical pharmacology of non-steroidal anti-inflammatory drugs.
    Graham GG; Day RO; Champion GD; Lee E; Newton K
    Clin Rheum Dis; 1984 Aug; 10(2):229-49. PubMed ID: 6439458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.